[1] 韩梅,吴寒.我国弓形虫病研究进展[J].医学信息,2018,31(2):33-36.
[2] 邢燕,谷俊朝.弓形虫病研究进展[J].中国病原生物学杂志,2016,11(1):94-96.
[3] ALVARADO-ESQUIVEL C, SÁNCHEZ-ANGUIANO L F, BERUMEN-SEGOVIA L O, et al. Knowledge and Practices of Toxoplasmosis among Clinical Laboratory Professionals: A Cross-Sectional Study in Durango, Mexico[J]. Int J Environ Res Public Health, 2017, 14(11): pii: E1413.
[4] HENAO-MARTÍNEZ A F, FRANCO-PAREDES C, PALESTINE A G, et al. Symptomatic Acute Toxoplasmosis in Returning Travelers[J]. Open Forum Infect Dis, 2018, 5(4): ofy058.
[5] 李桂萍,崔蓉,张瑜.后天获得性弓形虫病11例误诊原因分析[J].临床误诊误治,2009,22(3):37.
[6] 高歌. 弓形虫病临床特征及诊治研究新进展[J].中国病原生物学杂志,2014,9(9):848-851.
[7] 张成芳,张海国,李瑾.弓形虫病免疫学诊断的研究进展[J].中华诊断学电子杂志,2017,5(1):59-61.
[8] RAHIMI-ESBOEI B, ZAREI M, MOHEBALI M, et al. Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis[J]. Korean J Parasitol, 2018, 56(2): 147-152.
[9] ALDAY P H, DOGGETT J S.Drugs in development for toxoplasmosis: advances, challenges, and current status[J]. Drug Des Devel Ther, 2017, 11: 273-293.
[10] 白冰,桑晓宇,周雅盼,等.弓形虫疫苗研究进展[J].中国人兽共患病学报,2017,33(12):1120-1124. |